Study #2025-0876
Phase 1 trial of engineered HSV-1 M032 in children and adults with newly diagnosed diffuse midline glioma after standard of care radiation
MD Anderson Study Status
Enrolling
Treatment Agent
M032
Description
The goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who have received standard-of-care radiation therapy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Glioma
Study phase:
Phase I
Physician name:
Gregory Friedman
Department:
Pediatrics
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.